Cargando…

Cost-effectiveness analysis of ultrasonography screening for nonalcoholic fatty liver disease in metabolic syndrome patients

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) can be diagnosed early by noninvasive ultrasonography; however, the cost-effectiveness of ultrasonography screening with intensive weight reduction program in metabolic syndrome patients is not clear. This study aims to estimate economic and clini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Phisalprapa, Pochamana, Supakankunti, Siripen, Charatcharoenwitthaya, Phunchai, Apisarnthanarak, Piyaporn, Charoensak, Aphinya, Washirasaksiri, Chaiwat, Srivanichakorn, Weerachai, Chaiyakunapruk, Nathorn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413221/ https://www.ncbi.nlm.nih.gov/pubmed/28445256 http://dx.doi.org/10.1097/MD.0000000000006585

Ejemplares similares

Comparison of noninvasive scoring systems for the prediction of nonalcoholic fatty liver disease in metabolic syndrome patients
por: Saokaew, Surasak, et al.
Publicado: (2020)

Clinical predictive score for detecting nonalcoholic fatty liver disease with significant fibrosis in patients with metabolic syndrome
por: Kositamongkol, Chayanis, et al.
Publicado: (2021)

Economic burden of non-alcoholic steatohepatitis with significant fibrosis in Thailand
por: Phisalprapa, Pochamana, et al.
Publicado: (2021)

Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD): A PRISMA-compliant systematic review and network meta-analysis
por: Sawangjit, Ratree, et al.
Publicado: (2016)

Accuracy and the factors influencing the accuracy of death certificates completed by first-year general practitioners in Thailand
por: Washirasaksiri, Chaiwat, et al.
Publicado: (2018)

Clinical Differences and Non-Alcoholic Fatty Liver Disease-Related Factors of Lean and Non-Lean Patients with Metabolic Syndrome
por: Boonchai, Punyisa, et al.
Publicado: (2022)

Association of non-alcoholic fatty liver disease and all-cause mortality in hospitalized cardiovascular disease patients: A systematic review and meta-analysis
por: Saokaew, Surasak, et al.
Publicado: (2021)

Cost–Utility and Budget Impact Analyses of Oral Chemotherapy for Stage III Colorectal Cancer: Real-World Evidence after Policy Implementation in Thailand
por: Phisalprapa, Pochamana, et al.
Publicado: (2023)

“MURAL” model to predict bleeding from mural-based lesions in potential small bowel bleeding may improve diagnostic capability and decrease cost
por: Limsrivilai, Julajak, et al.
Publicado: (2022)

Cardiometabolic risk factors in Thai individuals with prediabetes treated in a high‐risk, prevention clinic: Unexpected relationship between high‐density lipoprotein cholesterol and glycemia in men
por: Srivanichakorn, Weerachai, et al.
Publicado: (2018)

Long-Term Outcomes Associated with NAFLD, ASCVD, and All-Cause Mortality of Patients with Metabolic Syndrome
por: Jitrukthai, Suchanart, et al.
Publicado: (2022)

Care maps are an effective tool for optimizing quality of care of infectious diseases in a resource-constrained short-stay ambulatory care setting
por: Washirasaksiri, Chaiwat, et al.
Publicado: (2021)

Fasting plasma glucose and HbA1c levels predict the risk of type 2 diabetes and diabetic retinopathy in a Thai high-risk population with prediabetes
por: Washirasaksiri, Chaiwat, et al.
Publicado: (2022)

Knowledge, attitude, and behaviors toward liver health and viral hepatitis-related liver diseases in Thailand
por: Phisalprapa, Pochamana, et al.
Publicado: (2021)

Severe enteropathy with villous atrophy in prolonged mefenamic acid users – a currently under-recognized in previously well-recognized complication: Case report and review of literature
por: Kaosombatwattana, Uayporn, et al.
Publicado: (2017)

Increasing glycaemia is associated with a significant decline in HDL cholesterol in women with prediabetes in two national populations
por: Washirasaksiri, Chaiwat, et al.
Publicado: (2021)

Disease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spain
por: Romero-Gomez, Manuel, et al.
Publicado: (2020)

Fatty Pancreas: Linking Pancreas Pathophysiology to Nonalcoholic Fatty Liver Disease
por: Rugivarodom, Manus, et al.
Publicado: (2022)

Factors affecting mortality and resource use for hospitalized patients with cirrhosis: A population-based study
por: Charatcharoenwitthaya, Phunchai, et al.
Publicado: (2017)

Temporal trend of disease recognition, treatment paradigm, and clinical outcomes of Crohn disease in Thailand from 2000 through 2017: Is early use of thiopurines beneficial?
por: Limsrivilai, Julajak, et al.
Publicado: (2020)

1345. Clinical Characteristics and Outcomes of Mild to Moderate COVID-19 Patients with Abnormal Chest Radiologic Findings Treated in the Hospitels in Thailand
por: Sayabovorn, Naruemit, et al.
Publicado: (2023)

Use of a Diabetes Self-Assessment Score to Predict Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Kim, Gyuri, et al.
Publicado: (2015)

Dietary Composition and Its Association with Newly Diagnosed Nonalcoholic Fatty Liver Disease and Insulin Resistance
por: Charatcharoenwitthaya, Phunchai, et al.
Publicado: (2021)

Effects of Synbiotics, Probiotics, and Prebiotics on Liver Enzymes of Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis
por: Kanchanasurakit, Sukrit, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis
por: Sinn, Dong Hyun, et al.
Publicado: (2016)

Risk factors of nonalcoholic fatty liver disease in healthy women
por: Guan, Hui, et al.
Publicado: (2023)

Validation of the Fatty Liver Index for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Chinese
por: Huang, Xiaolin, et al.
Publicado: (2015)

Very-low-dose aspirin and surveillance colonoscopy is cost-effective in secondary prevention of colorectal cancer in individuals with advanced adenomas: network meta-analysis and cost-effectiveness analysis
por: Veettil, Sajesh K., et al.
Publicado: (2021)

Nonalcoholic fatty liver was associated with asymptomatic gallstones in a Chinese population
por: Qiao, Qiao-Hua, et al.
Publicado: (2017)

Efficacy of probiotics on nonalcoholic fatty liver disease: A meta-analysis
por: Zhou, Xiangyu, et al.
Publicado: (2023)

Development of de novo nonalcoholic fatty liver disease following pancreatectomy
por: Patel, Vanisha, et al.
Publicado: (2023)

The metabolic influence of duodenal mucosal resurfacing for nonalcoholic fatty liver disease
por: Chuang, Te-Jung, et al.
Publicado: (2023)

Effects of Telemedicine on Obese Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Saokaew, Surasak, et al.
Publicado: (2021)

Association of resting heart rate with nonalcoholic fatty liver disease in postmenopausal women
por: Kim, Hong-Bae, et al.
Publicado: (2020)

A nomogram incorporated lifestyle indicators for predicting nonalcoholic fatty liver disease
por: Peng, Kaili, et al.
Publicado: (2021)

The Presence of White Matter Lesions Is Associated With the Fibrosis Severity of Nonalcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2016)

Nonalcoholic Fatty Liver Disease: A Negative Risk Factor for Colorectal Cancer Prognosis
por: You, Jie, et al.
Publicado: (2015)

Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD)
por: Golabi, Pegah, et al.
Publicado: (2018)

Candidate genes investigation for severe nonalcoholic fatty liver disease based on bioinformatics analysis
por: Qi, Shan, et al.
Publicado: (2017)

Association between Helicobacter pylori infection and nonalcoholic fatty liver: A meta-analysis
por: Liu, Rongqiang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pjajjbl7or4ak5pa4gf8kkjou1